| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $222K | -51.9% |
| SG&A Expense | $53K | -52.0% |
| Operating Income | -$344K | +46.5% |
| Interest Expense | $59K | -43.8% |
| Net Income | -$56K | +92.9% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $659 | +56.9% |
| Total Assets | $659 | +56.9% |
| Current Liabilities | $432K | -67.3% |
| Total Liabilities | $446K | -70.1% |
| Stockholders' Equity | -$445K | +70.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62K | +10.0% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $62K | -6.1% |